Name: UMIN ID:
Unique ID issued by UMIN | UMIN000043463 |
---|---|
Receipt number | R000049623 |
Scientific Title | A prospective observational study of Atezolizumab plus Bevacizumab in patients with unresectable hepatocellular carcinoma |
Date of disclosure of the study information | 2021/03/01 |
Last modified on | 2024/03/04 10:19:23 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2021/02/28 12:25:52 | ||
2 | Update | 2021/05/26 17:46:19 | Institutions |
|
3 | Update | 2021/05/27 14:03:45 | Institutions |
|
4 | Update | 2021/06/22 12:58:57 | Recruitment status |
|
5 | Update | 2021/07/16 17:34:07 | Institutions |
|
6 | Update | 2021/09/09 12:04:06 | Institutions |
|
7 | Update | 2021/10/15 11:36:49 | Institutions |
|
8 | Update | 2021/10/15 11:45:10 | Institutions |
|
9 | Update | 2021/11/29 19:59:27 | Institutions |
|
10 | Update | 2022/05/26 15:49:21 | Recruitment status |
|
11 | Update | 2022/06/13 15:14:12 | Last name of contact person Last name of contact person Division name Name of person sending information Name of person sending information Division name |
|
12 | Update | 2023/09/01 09:22:22 | Number of participants that the trial has enrolled |
|
13 | Update | 2024/03/04 10:19:23 | Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Address |